ArticleMolecular therapy. Oncology2026

Dual targeting of PDPN and GD2 enhances CAR T cell efficacy against glioblastoma and promotes durable tumor control.

Julian Hübner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.